These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30851907)

  • 1. Evolution and predictive factors of quality of life in patients undergoing oncologic surgery for head and neck cancer: A prospective multicentric study.
    Bozec A; Schultz P; Gal J; Chamorey E; Chateau Y; Dassonville O; Poissonnet G; Demard F; Peyrade F; Saada E; Benezery K; Leysalle A; Santini L; Messaoudi L; Fakhry N
    Surg Oncol; 2019 Mar; 28():236-242. PubMed ID: 30851907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the information given to patients undergoing head and neck cancer surgery using the EORTC QLQ-INFO25 questionnaire: A prospective multicentric study.
    Bozec A; Schultz P; Gal J; Chamorey E; Chateau Y; Dassonville O; Poissonnet G; Santini J; Peyrade F; Saada E; Guigay J; Benezery K; Leysalle A; Santini L; Giovanni A; Messaoudi L; Fakhry N
    Eur J Cancer; 2016 Nov; 67():73-82. PubMed ID: 27616438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
    Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term quality of life and psycho-social outcomes after oropharyngeal cancer surgery and radial forearm free-flap reconstruction: A GETTEC prospective multicentric study.
    Bozec A; Demez P; Gal J; Chamorey E; Louis MY; Blanchard D; De Raucourt D; Merol JC; Brenet E; Dassonville O; Poissonnet G; Santini J; Peyrade F; Benezery K; Lesnik M; Berta E; Ransy P; Babin E
    Surg Oncol; 2018 Mar; 27(1):23-30. PubMed ID: 29549900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
    Veldhuis D; Probst G; Marek A; Noack V; Ural A; Adamietz I; Dazert S; Minovi A
    Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):215-24. PubMed ID: 25575842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the information given to patients undergoing total pharyngolaryngectomy and quality of life: a prospective multicentric study.
    Bozec A; Schultz P; Gal J; Chamorey E; Chateau Y; Dassonville O; Poissonnet G; Peyrade F; Saada E; Guigay J; Benezery K; Leysalle A; Santini L; Giovanni A; Messaoudi L; Fakhry N
    Eur Arch Otorhinolaryngol; 2019 Sep; 276(9):2531-2539. PubMed ID: 31240456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Kim SA; Roh JL; Lee SA; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Cancer; 2016 Jan; 122(1):131-40. PubMed ID: 26371775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The personality and quality of life in HNSCC patients following treatment.
    Aarstad HJ; Aarstad AK; Birkhaug EJ; Bru E; Olofsson J
    Eur J Cancer; 2003 Sep; 39(13):1852-60. PubMed ID: 12932662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
    Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3495-3505. PubMed ID: 31529149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsurgical head and neck reconstruction after oncologic ablation: a study analyzing health-related quality of life.
    Momeni A; Kim RY; Kattan A; Lee GK
    Ann Plast Surg; 2013 Apr; 70(4):462-9. PubMed ID: 23486123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of life outcome in patients with head and neck squamous cell cancer treated using chemoradiotherapy.
    Tsukada K; Seino Y; Yamashita T
    Auris Nasus Larynx; 2024 Aug; 51(4):674-679. PubMed ID: 38704895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy.
    Oliveira KG; von Zeidler SV; Podestá JR; Sena A; Souza ED; Lenzi J; Bissoli NS; Gouvea SA
    BMC Cancer; 2014 Jan; 14():39. PubMed ID: 24460780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer.
    Pierre CS; Dassonville O; Chamorey E; Poissonnet G; Ettaiche M; Santini J; Peyrade F; Benezery K; Sudaka A; Bozec A
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):801-7. PubMed ID: 23771320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas.
    Aarstad HJ; Aarstad AK; Lybak S; Monge O; Haugen DF; Olofsson J
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):9-15. PubMed ID: 16205902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy.
    Fang FM; Chien CY; Kuo SC; Chiu HC; Wang CJ
    Acta Oncol; 2004; 43(6):571-8. PubMed ID: 15370615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life.
    Derks W; De Leeuw JR; Hordijk GJ; Winnubst JA
    Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):399-405. PubMed ID: 12969340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of radiotherapy on the quality of life in patients with early-stage clinical head and neck cancer.
    Milecki J; Żmijewska-Tomczak M; Osmola K; Wierzbicka M
    Otolaryngol Pol; 2021 May; 75(5):1-8. PubMed ID: 34552020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.